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doi:10.1016/j.jtcvs.2006.03.017bjective: Detachment of endothelial cells may represent serious injury of the
ndothelium after cardiopulmonary bypass. We investigated whether the extent of
ndothelial injury is related to the type of cardiopulmonary bypass system used
conventional or minimized) and determined circulating endothelial cells as well as
on Willebrand factor and soluble thrombomodulin.
ethods: Twenty patients scheduled for elective coronary bypass grafting were
andomly assigned to either the minimal extracorporeal circulation system or the
tandard cardiopulmonary bypass. Ten healthy volunteers served as controls. Cir-
ulating endothelial cells per milliliter of full blood were perioperatively determined
y immunomagnetic cell separation technique. Endothelial plasma markers were
easured by enzyme-linked immunosorbent assay.
esults: Preoperative circulating endothelial cell numbers did not differ between the
xperimental groups, but were significantly higher than in the healthy controls (18.6 
.6 vs 7.2  3.8, P  .001). At 6 hours, circulating endothelial cell numbers
ncreased significantly compared with baseline in both experimental groups and
eaked at 12 hours after cardiopulmonary bypass initiation, each time with significantly
ower values in the minimal extracorporeal circulation group (6 hours: 44.0  9.9 vs
9.6 9.8, P .007; 12 hours: 48.1 6.8 vs 31.8 7.1, P .001). Likewise, von
illebrand factor and soluble thrombomodulin postoperatively increased in both
roups with a tendency toward lower levels in the minimal extracorporeal circula-
ion group. Although circulating endothelial cells gradually declined, continually
ith lower numbers in the minimal extracorporeal circulation group, the endothelial
lasma markers remained elevated during observation time.
onclusions: Circulating endothelial cells represent a novel marker of the intrinsic
ndothelial damage caused by cardiopulmonary bypass. Its analysis facilitates the
valuation of cardiopulmonary bypass modifications as the minimal extracorporeal
irculation system could be proven to be less injurious to endothelium and myo-
ardium.
ince its first successful clinical use in the early 1950s, cardiopulmonary
bypass (CPB) has undergone a variety of technical improvements. Nonethe-
less, there are recent trends in minimizing or completely avoiding the current
PB, mainly to reduce the blood–foreign surface contact. According to the Society
f Thoracic Surgeons National Database, serious complications develop in 20% of
ow-risk patients after cardiac surgery.1 More than 20 years ago, Kirklin 
olleagues2 reported an activation of the complement system after CPB. 
ommon knowledge that CBP triggers a global defense reaction of the whole body,
sually denoted as systemic inflammatory response syndrome.3,4 An option to
ttenuate the deleterious CPB-related effects might be the strict reduction of foreign
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CSPurfaces, avoidance of blood–air contact, and modification
f the pump itself. The advantages of such a minimized
ystem have been shown in clinical studies by our group and
thers.5,6 The minimal extracorporeal circulation (MECC
ircuit used is a closed, fully heparin-coated, and precon-
ected extracorporeal circulation system consisting of a
iffusion membrane oxygenator and a centrifugal pump but
oregoing a reservoir for pericardial suction blood.
The contact activation of blood cells with artificial surfaces
nd air, the operative trauma itself, ischemia/reperfusion in-
ury, hemodilution, and endotoxemia caused by intestinal
ypoperfusion are the predominant triggers of complement
ctivation, alteration of the cytokine steady-state, alteration of
oagulation and fibrinolysis, activation of immune-competent
ells, and endothelial damage.7 So far, assessment of end-
helial function has been accomplished by analysis of spe-
ific plasma markers such as von Willebrand factor (vWf),
oluble thrombomodulin (sTM), soluble E-selectin, tissue
lasminogen activator, or soluble endothelial cell protein C
eceptor. More recently, a novel method for assessing vas-
ular integrity was established: the determination of circu-
ating endothelial cells (CECs) immunomagnetically sepa-
ated from the peripheral blood. Under physiologic
onditions, CECs occur in the blood of healthy individuals
n the range of 5 cells/mL, whereas elevated numbers are
ound among those with sickle cell anemia, rickettsial, and
ytomegalovirus infections, Behçet disease, various forms
f vasculitis, and type 2 diabetes mellitus.8-10 Mutin and
olleagues11 detected elevated CECs in patients with ac
yocardial infarction and unstable angina. CECs have also
een shown to correlate with disease status and response to
reatment in patients with renal transplant rejection or acute
yeloid leukemia.12,13
In this pilot study, we investigated the endothelial acti-
ation in patients with cardiovascular disease before, dur-
ng, and after cardiac surgery. The endothelial disturbance
as sought to delineate by enumeration of CECs and anal-
sis of vWf and sTM. By randomly using the MECC system
r standard CPB, we evaluated the endothelial damage
nduced by each system.
atients and Methods
he study was approved by the local ethical board. Twenty
ondiabetic patients scheduled for elective coronary artery by-
ass graft surgery were prospectively randomized into 2 groups
f 10 patients each according to the type of CPB used. Exclu-
ion criteria were ejection fraction less than 25%, age more than
0 years, emergency operation, redo or combined cardiac sur-
ery, severe renal dysfunction with or without requiring dialy-
is, and hepatic disorder. The randomization plan (20 patients in
sub-blocks) was generated by an open-access web-based tool
http://www.tufts.edu/ gdallal/PLAN.HTM). For standard
PB, a polypropylene, microporous (0.2 m), hollow-fiber
xygenator (Jostra Quadrox, Maquet Cardiopulmonary AG, F
92 The Journal of Thoracic and Cardiovascular Surgery ● Auguirrlingen, Germany) with cardiotomy suction reservoir was
sed with a roller pump (Jostra HL 20, Maquet Cardiopulmo-
ary AG). The MECC system introduces a new polymeth-
lpenten hollow-fiber oxygenator with a plasmatight diffusion
embrane (Jostra Quadrox D, Maquet Cardiopulmonary AG)
nd a centrifugal pump (Jostra RotaFlow, Maquet Cardiopul-
onary AG), whereas fundamental components are reduced to
inimal elements as arterial and venous lines or completely
mitted as the cardiotomy reservoir. Both systems including the
xygenators were heparin coated and ensured a nonpulsatile
ow of 2.0 to 2.5 L · min · m2 body surface area. Ten healthy
olunteers served as controls (7 males, 3 females) to evaluate the
reoperative endothelial activation status of patients with cardiovas-
ular disease.
nesthesia
nesthesia was induced with 1 g/kg sufentanil, 0.2 mg/kg eto-
idate, 0.04 mg/kg midazolam, and 0.15 mg/kg cisatracurium.
nesthesia was maintained with sufentanil, totaling 1 g/kg/h and
idazolam 0.1 mg/kg/h; supplemental sevoflurane was given until
PB. No volatile drugs were added during CPB.
peration
pproximately 300 IU heparin per kilogram of total body weight
as administered for systemic anticoagulation to aim at a target
ctivated coagulation time of 350 to 400 seconds. The arterial
annula was placed in the ascending aorta, and the venous 2-stage
annula was placed in the right atrium. Lines were connected with
iligence to avoid gaseous bubbles. Myocardial protection was
chieved by antegrade administration of Calafiore blood cardio-
legia. Mild hypothermia (31°C-32.5°C) was instituted immedi-
tely after CPB start, measured by an esophageal temperature
robe. Low-dose aprotinin (1106 IU) was administrated in the
PB priming solution. In addition, the anesthesiologist applied
106 IU aprotinin per hour of CPB. The aorta was crossclamped
hile the distal anastomoses were completed. The proximal vein
nastomoses were established with partial occlusion of the ascend-
ng aorta while the patient was rewarmed. Blood from the surgical
ite was collected in the cardiotomy reservoir in the standard CPB
roup or in a cell-saving device in the MECC group. Thereby, cell
aving was processed at a certain blood volume (0.5 L), and
alvaged blood was retransfused only if necessary. After CPB,
rotamine (1 mg/100 units of total heparin) was administered to
ntagonize heparin.
amples and Endothelial Markers
nalysis was performed preoperatively, 30 minutes, 6 hours, 12
ours, 24 hours, and 48 hours after CPB initiation. Blood was
ollected into citrate tubes and centrifuged at 3345g for 15 minutes
Heraeus Multifuge 1 S-R, Osterode, Germany), and supernatant
as frozen at 70°C for batch analysis. vWf antigen (Ag) was
easured by immunoturbidimetric determination using the Dade
ehring vWf:Ag test kit (Dade Behring Marburg GmbH, Marburg,
ermany). For determination of sTM concentration a commercial
olid-phase sandwich enzyme-linked immunosorbent assay kit was
sed (human sCD141 ELISA kit, Diaclone Research, Besançon,
rance).
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Pirculating Endothelial Cell Analysis
lood samples for CEC quantification were taken last in EDTA
ubes to avoid contamination by endothelial cells from the vessel
all. CEC quantification was done immediately or if unavoidable
o longer than 8 hours after collection and storage at 4°C. All
aboratory work was performed in blinded fashion with respect to
he identity of the samples.
To isolate CECs, we used M-450 Dynabeads, 4.5-m diameter
olystyrene beads coated with rat anti-mouse immunoglobulin-G1
Dynal, Hamburg, Germany) coupled with murine anti-human
D146 antibody (Biocytex, Marseilles, France). One milliliter of
lood was diluted with 1 mL of phosphate-buffered saline (PBS)
ontaining 0.1% bovine serum albumin (BSA). Twenty microliters of
cR blocking agent (Miltenyi, Bergisch-Gladbach, Germany) were
dded to prevent nonspecific leukocyte binding and incubated with
00 L anti-CD146-coated Dynabeads (8106 beads/10 L anti-
D 146) for 60 minutes while gently agitating in a head-over-head
ixer. Cells bound to anti-CD146-coupled beads were separated
rom blood in a magnet (Dynal MPC), washed 4 times with
BS-BSA, and incubated in 100 L of rhodamine-labeled Ulex-
uropaeus-Agglutinin-1 solution (1:10 dilution, Linaris Wertheim,
ermany) for 1 hour on an orbital shaker in darkness. Cells were
ashed, resuspended in 100 L PBS-BSA, and counted in a
ageotte chamber (Brand, Wertheim, Germany) with a fluorescent
icroscope (Leica DMLB, Leica Microsystems GmbH, Wetzlar,
ermany) equipped with an excitation filter N2 (BP 546/12). In
ccordance with others, CECs were identified as well-delineated
ound or oval rhodamine-labeled cells with a size of 10 to 40 m
nd with more than 4 beads attached.14 Enumeration of CECs wa
one 2 times each sample, in case of deviation, and the average
alue was taken. Figure 1 shows a CEC caught by s
agnetobeads.
tatistical Analysis
ll data were stored and analyzed using the SPSS statistical
ackage 12.0 (SPSS Inc. Chicago, Ill). Descriptive statistics were
omputed for variables of interest. The computed statistics in-
luded mean and standard deviations. Because of the small number
f patients and controls and the low power resulting in a failure to
igure 1. Representative microphotography of a rhodamine-
abeled CEC caught by several magnetobeads. Fluorescent mi-
roscopy, 20 magnification.alsify a null hypothesis, statistical tests regarding normal distri- i
The Journal of Thoracicl
ution of variables were not carried out. Consequently, nonpara-
etric tests were used. For the preoperative moment, values were
vailable for all 3 groups; therefore, differences were analyzed
ith the Kruskal-Wallis test and, if necessary, in pairs between the
roups with the Mann-Whitney U test including Bonferroni cor-
ection, which means an alpha level of 0.05/3  0.017. After CPB
nitiation, values were available only in the 2 experimental groups,
nd comparisons were made with the Mann-Whitney U test each
ime (alpha level  0.05/5  0.01). Within-group comparisons
etween all moments were made with the Friedman test. If the
ypothesis of equality of all 6 moments was rejected, comparisons
etween the preoperative moment and the other 5 postoperative
imes were made by using Wilcoxon tests with Bonferroni correc-
ion (alpha level 0.05/5 0.01). Generally, all P values resulted
rom 2-sided tests and without Bonferroni correction a P value of
ess than .05 was considered to indicate statistical significance.
esults
atients’ perioperative demographics are shown in Table
here was no statistical difference between the experimen-
al groups regarding age, gender ratio, preoperative ejection
raction, CPB duration, number of grafts, and intensive care
nit stay. Four patients in the standard CPB group and 5
atients in the MECC group had a history of myocardial
nfarction. One patient in the MECC group had a recent
yocardial infarction within the last 30 days (19 days). The
ostoperative course was uneventful in all patients. Only 1
atient in the standard CPB group required homologous
lood transfusion on postoperative day 2. Retransfusion of
ell-saver blood was not required in any of the patients in
he MECC group.
irculating Endothelial Cells
reoperative CEC numbers (cells per milliliter of blood) did
ot differ between the experimental groups (standard CPB:
7.8  3.9, MECC: 19.3  7.1; P  .971) but were
ignificantly higher than in the healthy controls (7.2  3.8;
  .001 for both of the 2 comparisons) (Figure 2). D
PB, CECs demonstrated only a slight elevation. At 6
ours, CECs increased significantly compared with baseline
ABLE 1. Patients’ demographics
riteria Standard CPB MECC P value
umber (n) 10 10
ge (y) 65.2 9.6 67.5 10.3 .61
ale/female 8/2 7/3 .27
reoperative EF 0.50 0.07 0.46 0.15 .55
revious MI (30 d) 4 (0) 5 (1) .65
PB time (min) 102.6 24.0 90.2 35.4 .27
rafts 3.80  0.79 3.50 0.85 .42
CU stay (d) 1.1 0.31 1.1 0.31 .99
ECC, Minimal extracorporeal circulation; CPB, cardiopulmonary bypass;
F, ejection fraction; MI, myocardial infarction; ICU, intensive care unit.n both groups and peaked at 12 hours after CPB initiation,
and Cardiovascular Surgery ● Volume 132, Number 2 293
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CSPach time with significantly lower values in the MECC group
6 hours: 44.0  9.9 vs 29.6 9.8, P .007; 12 hours:
8.1 6.8 vs 31.8  7.1, P  .001). At 24 and 48 hours,
ECs gradually decreased again with lower numbers in the
ECC group (24 hours: 41.5 9.3 vs 30.7 7.0, P .011;
8 hours: 38.6  7.9 vs 29.5  5.9, P  .023). Friedman
ests documented significant changes in CECs in both ex-
erimental groups (P  .001). At any time, postoperative
alues were significantly higher than initial values (Wil-
oxon test: P  .005 for each test).
on Willebrand Factor Antigen
reoperative vWf:Ag (international units/deciliter) did not
iffer between the experimental groups (standard CPB:
43.7 48.9, MECC: 126.4 33.7; Mann-Whitney U test:
 .436), but its concentration strongly tended to higher
alues in both groups of patients with cardiovascular dis-
ase compared with the healthy controls (99.5  22.1,
tandard CPB: Mann-Whitney U test: P  .019; MECC:
ann-Whitney U test: P  .075) (Figure 3). After surger
Wf:Ag increased in both experimental groups (Friedman
est: P  .001, Wilcoxon test: P  .005 for each test). Even
f the postoperative plasma concentrations of vWf:Ag
ended to be lower in the MECC group (6 hours: 191.1 
9.4 vs 230.0  83.0; 12 hours: 215.3  65.5 vs 267.3 
8.0; 24 hours: 242.9  64.9 vs 298.8  76.2; 48 hours:
11.1  76.4 vs 359.8  56.4), differences between the
roups were not statistically significant (Mann-Whitney U
est: P  .085 for each test).94 The Journal of Thoracic and Cardiovascular Surgery ● Auguoluble Thrombomodulin
lasma concentration of sTM (nanograms/milliliter) was
imilar in preoperative cardiovascular patients and
ealthy controls (standard CPB 2.3  1.3, MECC 1.8 
.9, controls 1.7  0.8; Kruskal-Wallis test: P  .638)
Figure 4). Friedman tests documented significa
hanges within both experimental groups (P  .001).
hereas in the standard CPB group the postoperative
TM concentrations were significantly higher than pre-
perative concentrations at any time (Wilcoxon test: P 
005 for each test), only the 48-hour increase was statis-
ically significant (Wilcoxon test: P  .005) in the MECC
roup. Nonetheless, there was no difference between the
roups at any postoperative time.
iscussion
o our knowledge, this is the first study investigating the
PB-related endothelial activation by evaluation of
ECs. The particular feature of CECs is that they not
nly unveil endothelial damage but also correlate with
he activity and degree of endothelial injury.15,16 CECs in
ur healthy volunteers were in the range of 7 cells/mL,
hich meets current results of other groups.10,17 Mutin
nd colleagues11 observed elevated CECs in patients 
o 24 hours after acute myocardial infarction, whereas
atients with stable angina did not show such phenom-
na. However, we detected high CEC numbers preoper-
tively in our elective patients with stable angina.
ssuming Mutin and colleagues used the same separation
Figure 2. Course of circulating endothelial cells
(CECs) in patients with cardiovascular disease be-
fore, during, and after surgery. CECs increased sig-
nificantly in both groups post-CPB versus pre-CPB,
each time with lower numbers in the MECC group
versus standard CPB group. CEC enumeration in
healthy controls indicated a higher endothelial
baseline activity in patients with cardiovascular
disease. CPB, Cardiopulmonary bypass;MECC,min-
imal extracorporeal circulation.
Figure 3. von Willebrand factor (vWf) plasma
concentration increased significantly after CPB
versus preoperative with a tendency toward
lower values in the MECC group versus standard
CPB group. vWf values of controls were lower
than preoperative values of patients with cardio-
vascular disease. CPB, Cardiopulmonary bypass;
MECC, minimal extracorporeal circulation.st 2006
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Pechnique and criteria for endothelial cell identification,
e conclude that there has to be a difference in the
everity of patients’ cardiovascular atherosclerosis. Par-
icularly, if these results are compared with the results in
ur healthy volunteers, we have to presume a higher
ndothelial baseline activity in patients with cardiovas-
ular disease that might be supported by likewise ele-
ated vWf. sTM was not elevated in our patients with
ardiovascular disease, at least not preoperatively. This
losely resembles the results of Chong and colleague18
ho observed a positive correlation between CECs and
Wf but not between CECs and sTM.
The fact that CECs increase significantly after CPB
ight indicate an additional or new endothelial distur-
ance. Because CECs remained nearly unchanged in both
etups during CPB, we do not assume a mechanical
rigger like direct vascular manipulation during cannula-
ion or surgery. The delayed increase more likely indi-
ates a mediated mechanism of endothelial detachment
aused by direct neutrophil attack, cytokines, and pro-
eases.10 In agreement with the theory that activa
eutrophils interfere with endothelial cell contact, Scholz
nd colleagues19 investigated the modulation of endoth-
ial junction molecules by neutrophils isolated from pa-
ients undergoing cardiac surgery before and during CPB.
hey observed an impairment of the endothelial integrity
y relocation of the zonula adherens molecule -catenin
aused only by neutrophils isolated at the end of CPB.
ue to these results, CPB triggers a time-dependent
ctivation of neutrophils that dissolve the endothelial
onnectivity and induce detachment of endothelial cells.
he detached endothelial cells are floating in the blood-
tream and can be detected by sufficiently sensitive meth-
ds. CD146 is expressed almost exclusively on mature
ndothelial cells, the exception being some tumor cell
ines.20 The immunomagnetic isolation technique w
sed is a modified method used by Woywodt and col-
eagues.14 In addition, we determined endothelial plasm
arkers such as vWf and sTM, which are known to be
elated to endothelial damage and capable of predicting
rognostic outcomes.18,21,22 CECs, vWf, and sTM were f
The Journal of Thoracicowest preoperatively, remained low during CPB, and
ere elevated 6 hours after CPB initiation in both groups.
hile vWf and sTM further increased during observation
ime, CECs peaked at 12 hours and decreased further on.
One major aim of our study was the comparison of 2
ifferent CPB setups. Although the endothelial markers
esponded similarly to CPB in both groups, the absolute
alues were lower or at least tended to be lower in the
ECC group. In regard to the differences in the CPB
etups, we assume that any use of different components
ight have an impact on inflammation-mediated endo-
helial function. The cardiotomy suction device increases
he artificial surface area and introduces a blood–air
nterface, which both trigger a strong activation of cel-
ular components.23,24 Retransfusion of pericardial suctio
lood reinforces the inflammatory response.25,26 Several stud-
es revealed advantages of centrifugal over-roller pumps in
egard to cellular activation, especially in the long term.27-29
inally, the oxygenators, even if structurally almost identi-
al, differ with regard to the hollow-fiber material and
ightness. The membrane in the Quadrox D (MECC system)
as no pores, thus preventing air from entering the circuit.
urthermore, the special oxygenator coating aims at de-
reasing the inherent pressure gradient resulting in less
emolysis and decreased release of inflammatory mediators.
owever, in our study we compared the CPB systems as
hole units well knowing that the influence of each com-
onent requires further analysis.
One of the limitations of this study is the relatively
mall number of patients in both experimental groups and
he inequality between study groups and controls. Enroll-
ng more patients would have increased the power of the
tudy. Additional CEC isolation from different sampling
ites, for example, the coronary sinus or pulmonary
eins, would have delivered new insights into the origin
f CECs and the potential correlation to organ ischemia.
tepwise modification of CPB would have allowed state-
ents about the importance of the particular components
or endothelial damage. All this must be subjected to
Figure 4. Soluble Thrombomodulin (sTm) in-
creased significantly post-CPB versus pre-CPB.
Baseline values of patients with cardiovascular
disease did not differ from those of controls.
CPB, Cardiopulmonary bypass; MECC, minimal
extracorporeal circulation.urther studies.
and Cardiovascular Surgery ● Volume 132, Number 2 295
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CSPonclusion
ECs represent a novel marker enabling the assessment of
ndothelial injury. In contrast to well-established plasma
arkers, CECs seem to be more accurate in detecting the
ntrinsic endothelial damage. Patients with cardiovascular
isease not only have a higher endothelial baseline activity
han the healthy population but also sustain additional dam-
ge contingent on the CPB system used. Our results indicate
hat the MECC system may be less injurious to endothelium
han the standard CPB. As this was a pilot study, further
nvestigations are needed to validate our observations.
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